生物学的インプラント市場：製品、投与方法、用途別-2025-2030年の世界予測

生物学的インプラント市場の2023年の市場規模は337億3,000万米ドル、2024年には409億米ドルに達すると予測され、2030年にはCAGR 21.36％で成長し、1,308億4,000万米ドルに達すると予測されています。

生物学的インプラントは、自然の機能を代替または補助するために体内に挿入される装置または組織を指します。これらのインプラントには、整形外科用インプラント、歯科用インプラント、心臓血管用インプラント、神経用インプラントなど、幅広い製品が含まれます。生物学的インプラントの必要性が高まっているのは、このような医療介入の必要性をもたらす加齢関連疾患、慢性疾患、事故の増加に起因しています。最終用途は病院、診療所、専門研究センターなど多岐にわたる。市場成長は主に、糖尿病、がん、心血管疾患、整形外科疾患の有病率の増加、医療技術の進歩、世界人口の高齢化に影響されています。生体活性化合物を組み込んだ新素材や生体適合性の向上は、技術革新の大きなチャンスとなります。さらに、3Dプリンティングやバイオプリンティングのようなデジタルヘルス技術の統合は、カスタムメイドの患者専用インプラントのためのものであり、拡張と適応のための新たなルートを切り開くものです。

市場成長に直面する主な制限と課題には、移植可能な機器の高コスト、複雑な規制承認プロセス、有害な免疫反応につながる可能性のある生体適合性の問題などがあります。これらの要因は、市場へのアクセスに影響を与え、新製品のイントロダクションを遅らせる可能性があります。技術革新は、費用対効果の高い生産技術の開発、生体模倣材料による生体適合性の向上、性能向上のためのナノテクノロジーの活用に重点を置くべきです。企業は、材料科学と再生医療の進歩の最前線に立ち続けるために、学術機関との研究提携に投資すべきです。市場の競争は激しく、大手企業は合併、買収、提携を通じて製品ポートフォリオの拡大を常に模索しています。企業はまた、カスタマイズによる患者固有のニーズへの対応や、各地域の規制・償還状況の改善にも注力する必要があります。こうした戦略的アプローチにより、市場への浸透を確実なものとし、新興経済圏で拡大するビジネスチャンスを活用することができます。

市場力学：急速に進化する生物学的インプラント市場の主要市場インサイトを公開

生物学的インプラント市場は、需要と供給のダイナミックな相互作用によって変貌を遂げています。このような市場力学の進化を理解することで、企業は十分な情報に基づいた投資決定、戦略的決定の精緻化、そして新たなビジネスチャンスの獲得に備えることができます。こうした動向を包括的に把握することで、企業は政治的、地理的、技術的、社会的、経済的な領域にわたる様々なリスクを軽減することができるとともに、消費者行動とそれが製造コストや購買動向に与える影響についてより明確に理解することができます。

• 市場促進要因
  • 精密インプラント外科手術の著しい進歩
  • 整形外科疾患や脊椎疾患などの疾病の発生と相まって高齢化人口の増加
  • 美容インプラントに対する意識の高まり
• 市場抑制要因
  • 高い製造コスト
• 市場機会
  • 3Dプリンティングやレーザー技術などの技術革新
  • 再生医療や組織工学の進歩
• 市場の課題
  • 乏しい償還問題

ポーターの5つの力：生物学的インプラント市場をナビゲートする戦略ツール

ポーターの5つの力フレームワークは、市場情勢の競合情勢を理解するための重要なツールです。ポーターのファイブフォース・フレームワークは、企業の競争力を評価し、戦略的機会を探るための明確な手法を提供します。このフレームワークは、企業が市場内の勢力図を評価し、新規事業の収益性を判断するのに役立ちます。これらの洞察により、企業は自社の強みを活かし、弱みに対処し、潜在的な課題を回避することができ、より強靭な市場でのポジショニングを確保することができます。

PESTLE分析：生物学的インプラント市場における外部からの影響の把握

外部マクロ環境要因は、生物学的インプラント市場の業績ダイナミクスを形成する上で極めて重要な役割を果たします。政治的、経済的、社会的、技術的、法的、環境的要因の分析は、これらの影響をナビゲートするために必要な情報を提供します。PESTLE要因を調査することで、企業は潜在的なリスクと機会をよりよく理解することができます。この分析により、企業は規制、消費者の嗜好、経済動向の変化を予測し、先を見越した積極的な意思決定を行う準備ができます。

市場シェア分析生物学的インプラント市場における競合情勢の把握

生物学的インプラント市場の詳細な市場シェア分析により、ベンダーの業績を包括的に評価することができます。企業は、収益、顧客ベース、成長率などの主要指標を比較することで、競争上のポジショニングを明らかにすることができます。この分析により、市場の集中、断片化、統合の動向が明らかになり、ベンダーは競争が激化する中で自社の地位を高める戦略的意思決定を行うために必要な知見を得ることができます。

FPNVポジショニング・マトリックス生物学的インプラント市場におけるベンダーのパフォーマンス評価

FPNVポジショニングマトリックスは、生物学的インプラント市場においてベンダーを評価するための重要なツールです。このマトリックスにより、ビジネス組織はベンダーのビジネス戦略と製品満足度に基づき評価することで、目標に沿った十分な情報に基づいた意思決定を行うことができます。4つの象限によりベンダーを明確かつ的確にセグメント化し、戦略目標に最適なパートナーやソリューションを特定することができます。

戦略分析と推奨生物学的インプラント市場における成功への道筋を描く

生物学的インプラント市場の戦略分析は、世界市場でのプレゼンス強化を目指す企業にとって不可欠です。主要なリソース、能力、業績指標を検討することで、企業は成長機会を特定し、改善に取り組むことができます。このアプローチにより、競合情勢における課題を克服し、新たなビジネスチャンスを活かして長期的な成功を収めるための体制を整えることができます。

本レポートでは、主要な注目分野を網羅した市場の包括的な分析を提供しています：

1.市場の浸透度：現在の市場環境の詳細なレビュー、主要企業による広範なデータ、市場でのリーチと全体的な影響力の評価。

2.市場の開拓度：新興市場における成長機会を特定し、既存分野における拡大可能性を評価し、将来の成長に向けた戦略的ロードマップを提供します。

3.市場の多様化：最近の製品発売、未開拓の地域、業界の主要な進歩、市場を形成する戦略的投資を分析します。

4.競合の評価と情報：競合情勢を徹底的に分析し、市場シェア、事業戦略、製品ポートフォリオ、認証、規制当局の承認、特許動向、主要企業の技術進歩などを検証します。

5.製品開発およびイノベーション：将来の市場成長を促進すると期待される最先端技術、研究開発活動、製品イノベーションをハイライトしています。

また、利害関係者が十分な情報を得た上で意思決定できるよう、重要な質問にも答えています：

1.現在の市場規模と今後の成長予測は？

2.最高の投資機会を提供する製品、セグメント、地域はどこか？

3.市場を形成する主な技術動向と規制の影響とは？

4.主要ベンダーの市場シェアと競合ポジションは？

5.ベンダーの市場参入・撤退戦略の原動力となる収益源と戦略的機会は何か？

目次

第1章 序文

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 市場の概要

第5章 市場洞察

• 市場力学
  • 促進要因
    • 精密インプラント手術の大きな進歩
    • 高齢化人口の増加と整形外科疾患や脊椎疾患などの疾患の増加
    • 美容インプラントへの意識の高まり
  • 抑制要因
    • 生産コストが高い
  • 機会
    • 3Dプリントやレーザー技術などの技術革新
    • 再生医療と組織工学の進歩
  • 課題
    • 払い戻しの問題がほとんどない
• 市場セグメンテーション分析
• ポーターのファイブフォース分析
• PESTEL分析
  • 政治的
  • 経済
  • 社交
  • 技術的
  • 法律上
  • 環境

第6章 生物学的インプラント市場：製品別

• 同種移植
• 自家移植
• 異種移植

第7章 生物学的インプラント市場投与方法別

• 注射可能
• 外科手術

第8章 生物学的インプラント市場：用途別

• 心臓血管インプラント
• 整形外科用インプラント
• 軟部組織インプラント

第9章 南北アメリカの生物学的インプラント市場

• アルゼンチン
• ブラジル
• カナダ
• メキシコ
• 米国

第10章 アジア太平洋地域の生物学的インプラント市場

• オーストラリア
• 中国
• インド
• インドネシア
• 日本
• マレーシア
• フィリピン
• シンガポール
• 韓国
• 台湾
• タイ
• ベトナム

第11章 欧州・中東・アフリカの生物学的インプラント市場

• デンマーク
• エジプト
• フィンランド
• フランス
• ドイツ
• イスラエル
• イタリア
• オランダ
• ナイジェリア
• ノルウェー
• ポーランド
• カタール
• ロシア
• サウジアラビア
• 南アフリカ
• スペイン
• スウェーデン
• スイス
• トルコ
• アラブ首長国連邦
• 英国

第12章 競合情勢

• 市場シェア分析2023
• FPNVポジショニングマトリックス, 2023
• 競合シナリオ分析
• 戦略分析と提言

企業一覧

• AbbVie Inc.
• Allografts.com
• Alphatec Spine, Inc.
• Altogen Labs
• Auto Tissue Berlin GmbH
• Baxter International, Inc.
• BioPolymer GmbH & Co. KG
• Citagenix Inc.
• Conmed Corporation
• CryoLife, Inc.
• Edward LifeSciences Corporation
• Integra LifeSciences Corporation
• Johnson & Johnson Services, Inc.
• KLS Martin, L.P. by Leibinger family
• Medical Device Business Services, Inc.
• Medtronic PLC
• NuVasive, Inc. by Globus Medical Inc
• RTI Surgical, Inc.
• Sanara MedTech, Inc.
• Stryker Corporation
• Surgenex LLC
• TissueTech, Inc.
• Zimmer Biomet Holdings, Inc.

LIST OF FIGURES

• FIGURE 1. BIOLOGICAL IMPLANTS MARKET RESEARCH PROCESS
• FIGURE 2. BIOLOGICAL IMPLANTS MARKET SIZE, 2023 VS 2030
• FIGURE 3. GLOBAL BIOLOGICAL IMPLANTS MARKET SIZE, 2018-2030 (USD MILLION)
• FIGURE 4. GLOBAL BIOLOGICAL IMPLANTS MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 5. GLOBAL BIOLOGICAL IMPLANTS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 6. GLOBAL BIOLOGICAL IMPLANTS MARKET SIZE, BY PRODUCT, 2023 VS 2030 (%)
• FIGURE 7. GLOBAL BIOLOGICAL IMPLANTS MARKET SIZE, BY PRODUCT, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 8. GLOBAL BIOLOGICAL IMPLANTS MARKET SIZE, BY MODE OF ADMINISTRATION, 2023 VS 2030 (%)
• FIGURE 9. GLOBAL BIOLOGICAL IMPLANTS MARKET SIZE, BY MODE OF ADMINISTRATION, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 10. GLOBAL BIOLOGICAL IMPLANTS MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
• FIGURE 11. GLOBAL BIOLOGICAL IMPLANTS MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 12. AMERICAS BIOLOGICAL IMPLANTS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 13. AMERICAS BIOLOGICAL IMPLANTS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 14. UNITED STATES BIOLOGICAL IMPLANTS MARKET SIZE, BY STATE, 2023 VS 2030 (%)
• FIGURE 15. UNITED STATES BIOLOGICAL IMPLANTS MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 16. ASIA-PACIFIC BIOLOGICAL IMPLANTS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 17. ASIA-PACIFIC BIOLOGICAL IMPLANTS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 18. EUROPE, MIDDLE EAST & AFRICA BIOLOGICAL IMPLANTS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 19. EUROPE, MIDDLE EAST & AFRICA BIOLOGICAL IMPLANTS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 20. BIOLOGICAL IMPLANTS MARKET SHARE, BY KEY PLAYER, 2023
• FIGURE 21. BIOLOGICAL IMPLANTS MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

• TABLE 1. BIOLOGICAL IMPLANTS MARKET SEGMENTATION & COVERAGE
• TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
• TABLE 3. GLOBAL BIOLOGICAL IMPLANTS MARKET SIZE, 2018-2030 (USD MILLION)
• TABLE 4. GLOBAL BIOLOGICAL IMPLANTS MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 5. GLOBAL BIOLOGICAL IMPLANTS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 6. BIOLOGICAL IMPLANTS MARKET DYNAMICS
• TABLE 7. GLOBAL BIOLOGICAL IMPLANTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 8. GLOBAL BIOLOGICAL IMPLANTS MARKET SIZE, BY ALLOGRAFTS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 9. GLOBAL BIOLOGICAL IMPLANTS MARKET SIZE, BY AUTOGRAFTS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 10. GLOBAL BIOLOGICAL IMPLANTS MARKET SIZE, BY XENOGRAFTS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 11. GLOBAL BIOLOGICAL IMPLANTS MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 12. GLOBAL BIOLOGICAL IMPLANTS MARKET SIZE, BY INJECTABLE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 13. GLOBAL BIOLOGICAL IMPLANTS MARKET SIZE, BY SURGICAL, BY REGION, 2018-2030 (USD MILLION)
• TABLE 14. GLOBAL BIOLOGICAL IMPLANTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 15. GLOBAL BIOLOGICAL IMPLANTS MARKET SIZE, BY CARDIOVASCULAR IMPLANTS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 16. GLOBAL BIOLOGICAL IMPLANTS MARKET SIZE, BY ORTHOPEDIC IMPLANTS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 17. GLOBAL BIOLOGICAL IMPLANTS MARKET SIZE, BY SOFT TISSUE IMPLANTS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 18. AMERICAS BIOLOGICAL IMPLANTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 19. AMERICAS BIOLOGICAL IMPLANTS MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 20. AMERICAS BIOLOGICAL IMPLANTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 21. AMERICAS BIOLOGICAL IMPLANTS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 22. ARGENTINA BIOLOGICAL IMPLANTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 23. ARGENTINA BIOLOGICAL IMPLANTS MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 24. ARGENTINA BIOLOGICAL IMPLANTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 25. BRAZIL BIOLOGICAL IMPLANTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 26. BRAZIL BIOLOGICAL IMPLANTS MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 27. BRAZIL BIOLOGICAL IMPLANTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 28. CANADA BIOLOGICAL IMPLANTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 29. CANADA BIOLOGICAL IMPLANTS MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 30. CANADA BIOLOGICAL IMPLANTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 31. MEXICO BIOLOGICAL IMPLANTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 32. MEXICO BIOLOGICAL IMPLANTS MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 33. MEXICO BIOLOGICAL IMPLANTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 34. UNITED STATES BIOLOGICAL IMPLANTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 35. UNITED STATES BIOLOGICAL IMPLANTS MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 36. UNITED STATES BIOLOGICAL IMPLANTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 37. UNITED STATES BIOLOGICAL IMPLANTS MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
• TABLE 38. ASIA-PACIFIC BIOLOGICAL IMPLANTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 39. ASIA-PACIFIC BIOLOGICAL IMPLANTS MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 40. ASIA-PACIFIC BIOLOGICAL IMPLANTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 41. ASIA-PACIFIC BIOLOGICAL IMPLANTS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 42. AUSTRALIA BIOLOGICAL IMPLANTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 43. AUSTRALIA BIOLOGICAL IMPLANTS MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 44. AUSTRALIA BIOLOGICAL IMPLANTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 45. CHINA BIOLOGICAL IMPLANTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 46. CHINA BIOLOGICAL IMPLANTS MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 47. CHINA BIOLOGICAL IMPLANTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 48. INDIA BIOLOGICAL IMPLANTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 49. INDIA BIOLOGICAL IMPLANTS MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 50. INDIA BIOLOGICAL IMPLANTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 51. INDONESIA BIOLOGICAL IMPLANTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 52. INDONESIA BIOLOGICAL IMPLANTS MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 53. INDONESIA BIOLOGICAL IMPLANTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 54. JAPAN BIOLOGICAL IMPLANTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 55. JAPAN BIOLOGICAL IMPLANTS MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 56. JAPAN BIOLOGICAL IMPLANTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 57. MALAYSIA BIOLOGICAL IMPLANTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 58. MALAYSIA BIOLOGICAL IMPLANTS MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 59. MALAYSIA BIOLOGICAL IMPLANTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 60. PHILIPPINES BIOLOGICAL IMPLANTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 61. PHILIPPINES BIOLOGICAL IMPLANTS MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 62. PHILIPPINES BIOLOGICAL IMPLANTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 63. SINGAPORE BIOLOGICAL IMPLANTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 64. SINGAPORE BIOLOGICAL IMPLANTS MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 65. SINGAPORE BIOLOGICAL IMPLANTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 66. SOUTH KOREA BIOLOGICAL IMPLANTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 67. SOUTH KOREA BIOLOGICAL IMPLANTS MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 68. SOUTH KOREA BIOLOGICAL IMPLANTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 69. TAIWAN BIOLOGICAL IMPLANTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 70. TAIWAN BIOLOGICAL IMPLANTS MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 71. TAIWAN BIOLOGICAL IMPLANTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 72. THAILAND BIOLOGICAL IMPLANTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 73. THAILAND BIOLOGICAL IMPLANTS MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 74. THAILAND BIOLOGICAL IMPLANTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 75. VIETNAM BIOLOGICAL IMPLANTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 76. VIETNAM BIOLOGICAL IMPLANTS MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 77. VIETNAM BIOLOGICAL IMPLANTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 78. EUROPE, MIDDLE EAST & AFRICA BIOLOGICAL IMPLANTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 79. EUROPE, MIDDLE EAST & AFRICA BIOLOGICAL IMPLANTS MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 80. EUROPE, MIDDLE EAST & AFRICA BIOLOGICAL IMPLANTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 81. EUROPE, MIDDLE EAST & AFRICA BIOLOGICAL IMPLANTS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 82. DENMARK BIOLOGICAL IMPLANTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 83. DENMARK BIOLOGICAL IMPLANTS MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 84. DENMARK BIOLOGICAL IMPLANTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 85. EGYPT BIOLOGICAL IMPLANTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 86. EGYPT BIOLOGICAL IMPLANTS MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 87. EGYPT BIOLOGICAL IMPLANTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 88. FINLAND BIOLOGICAL IMPLANTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 89. FINLAND BIOLOGICAL IMPLANTS MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 90. FINLAND BIOLOGICAL IMPLANTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 91. FRANCE BIOLOGICAL IMPLANTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 92. FRANCE BIOLOGICAL IMPLANTS MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 93. FRANCE BIOLOGICAL IMPLANTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 94. GERMANY BIOLOGICAL IMPLANTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 95. GERMANY BIOLOGICAL IMPLANTS MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 96. GERMANY BIOLOGICAL IMPLANTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 97. ISRAEL BIOLOGICAL IMPLANTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 98. ISRAEL BIOLOGICAL IMPLANTS MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 99. ISRAEL BIOLOGICAL IMPLANTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 100. ITALY BIOLOGICAL IMPLANTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 101. ITALY BIOLOGICAL IMPLANTS MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 102. ITALY BIOLOGICAL IMPLANTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 103. NETHERLANDS BIOLOGICAL IMPLANTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 104. NETHERLANDS BIOLOGICAL IMPLANTS MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 105. NETHERLANDS BIOLOGICAL IMPLANTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 106. NIGERIA BIOLOGICAL IMPLANTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 107. NIGERIA BIOLOGICAL IMPLANTS MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 108. NIGERIA BIOLOGICAL IMPLANTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 109. NORWAY BIOLOGICAL IMPLANTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 110. NORWAY BIOLOGICAL IMPLANTS MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 111. NORWAY BIOLOGICAL IMPLANTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 112. POLAND BIOLOGICAL IMPLANTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 113. POLAND BIOLOGICAL IMPLANTS MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 114. POLAND BIOLOGICAL IMPLANTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 115. QATAR BIOLOGICAL IMPLANTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 116. QATAR BIOLOGICAL IMPLANTS MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 117. QATAR BIOLOGICAL IMPLANTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 118. RUSSIA BIOLOGICAL IMPLANTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 119. RUSSIA BIOLOGICAL IMPLANTS MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 120. RUSSIA BIOLOGICAL IMPLANTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 121. SAUDI ARABIA BIOLOGICAL IMPLANTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 122. SAUDI ARABIA BIOLOGICAL IMPLANTS MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 123. SAUDI ARABIA BIOLOGICAL IMPLANTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 124. SOUTH AFRICA BIOLOGICAL IMPLANTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 125. SOUTH AFRICA BIOLOGICAL IMPLANTS MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 126. SOUTH AFRICA BIOLOGICAL IMPLANTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 127. SPAIN BIOLOGICAL IMPLANTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 128. SPAIN BIOLOGICAL IMPLANTS MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 129. SPAIN BIOLOGICAL IMPLANTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 130. SWEDEN BIOLOGICAL IMPLANTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 131. SWEDEN BIOLOGICAL IMPLANTS MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 132. SWEDEN BIOLOGICAL IMPLANTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 133. SWITZERLAND BIOLOGICAL IMPLANTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 134. SWITZERLAND BIOLOGICAL IMPLANTS MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 135. SWITZERLAND BIOLOGICAL IMPLANTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 136. TURKEY BIOLOGICAL IMPLANTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 137. TURKEY BIOLOGICAL IMPLANTS MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 138. TURKEY BIOLOGICAL IMPLANTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 139. UNITED ARAB EMIRATES BIOLOGICAL IMPLANTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 140. UNITED ARAB EMIRATES BIOLOGICAL IMPLANTS MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 141. UNITED ARAB EMIRATES BIOLOGICAL IMPLANTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 142. UNITED KINGDOM BIOLOGICAL IMPLANTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 143. UNITED KINGDOM BIOLOGICAL IMPLANTS MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 144. UNITED KINGDOM BIOLOGICAL IMPLANTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 145. BIOLOGICAL IMPLANTS MARKET SHARE, BY KEY PLAYER, 2023
• TABLE 146. BIOLOGICAL IMPLANTS MARKET, FPNV POSITIONING MATRIX, 2023

The Biological Implants Market was valued at USD 33.73 billion in 2023, expected to reach USD 40.90 billion in 2024, and is projected to grow at a CAGR of 21.36%, to USD 130.84 billion by 2030.

Biological implants refer to devices or tissues that are inserted into the body to replace or assist a natural function. These implants encompass a wide range of products, including orthopedic implants, dental implants, cardiovascular implants, and neural implants, among others. The growing necessity for biological implants stems from the rise in age-related conditions, chronic diseases, and accidents resulting in the need for such medical interventions. End-use applications are extensive, spanning across hospitals, clinics, and specialized research centers. Market growth is primarily influenced by the increasing prevalence of diabetes, cancer, cardiovascular diseases, and orthopedic disorders, paired with advancements in medical technology and an aging global population. New materials incorporating bioactive compounds and improved bio-compatibility present significant opportunities for innovation. Moreover, the integration of digital health technologies such as 3D printing and bioprinting for custom and patient-specific implants opens up new routes for expansion and adaptation.

The major limitations and challenges facing market growth include the high cost of implantable devices, complex regulatory approval processes, and potential biocompatibility issues, which could lead to adverse immune responses. These factors can affect market accessibility and slow down the introduction of new products. Innovations should focus on developing cost-effective production techniques, enhancing biocompatibility through biomimetic materials, and leveraging nanotechnology for improved performances. Businesses should invest in research partnerships with academic institutions to stay at the forefront of material science and regenerative medicine advancements. The nature of the market is competitive, with major players constantly seeking to expand their product portfolios through mergers, acquisitions, and collaborations. Companies should also focus on addressing patient-specific needs through customization and improving regulatory and reimbursement landscapes across different regions. This strategic approach will ensure market penetration and capitalize on the expanding opportunities within emerging economies.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Biological Implants Market

The Biological Implants Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

• Market Drivers
  • Significant advancement in precise implant surgical procedures
  • Increasing aging population coupled with instances of diseases such as orthopedic and spinal disorders
  • Rising awareness of cosmetic implants
• Market Restraints
  • High production cost
• Market Opportunities
  • Technological innovations such as 3D printing and laser technology
  • Advancements in regenerative medicine and tissue engineering
• Market Challenges
  • Scant reimbursement issues

Porter's Five Forces: A Strategic Tool for Navigating the Biological Implants Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Biological Implants Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Biological Implants Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Biological Implants Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Biological Implants Market

A detailed market share analysis in the Biological Implants Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Biological Implants Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Biological Implants Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Biological Implants Market

A strategic analysis of the Biological Implants Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Biological Implants Market, highlighting leading vendors and their innovative profiles. These include AbbVie Inc., Allografts.com, Alphatec Spine, Inc., Altogen Labs, Auto Tissue Berlin GmbH, Baxter International, Inc., BioPolymer GmbH & Co. KG, Citagenix Inc., Conmed Corporation, CryoLife, Inc., Edward LifeSciences Corporation, Integra LifeSciences Corporation, Johnson & Johnson Services, Inc., KLS Martin, L.P. by Leibinger family, Medical Device Business Services, Inc., Medtronic PLC, NuVasive, Inc. by Globus Medical Inc, RTI Surgical, Inc., Sanara MedTech, Inc., Stryker Corporation, Surgenex LLC, TissueTech, Inc., and Zimmer Biomet Holdings, Inc..

Market Segmentation & Coverage

This research report categorizes the Biological Implants Market to forecast the revenues and analyze trends in each of the following sub-markets:

• Based on Product, market is studied across Allografts, Autografts, and Xenografts.
• Based on Mode of Administration, market is studied across Injectable and Surgical.
• Based on Application, market is studied across Cardiovascular Implants, Orthopedic Implants, and Soft Tissue Implants.
• Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Segmentation & Coverage
• 1.3. Years Considered for the Study
• 1.4. Currency & Pricing
• 1.5. Language
• 1.6. Stakeholders

2. Research Methodology

• 2.1. Define: Research Objective
• 2.2. Determine: Research Design
• 2.3. Prepare: Research Instrument
• 2.4. Collect: Data Source
• 2.5. Analyze: Data Interpretation
• 2.6. Formulate: Data Verification
• 2.7. Publish: Research Report
• 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

• 5.1. Market Dynamics
  • 5.1.1. Drivers
    • 5.1.1.1. Significant advancement in precise implant surgical procedures
    • 5.1.1.2. Increasing aging population coupled with instances of diseases such as orthopedic and spinal disorders
    • 5.1.1.3. Rising awareness of cosmetic implants
  • 5.1.2. Restraints
    • 5.1.2.1. High production cost
  • 5.1.3. Opportunities
    • 5.1.3.1. Technological innovations such as 3D printing and laser technology
    • 5.1.3.2. Advancements in regenerative medicine and tissue engineering
  • 5.1.4. Challenges
    • 5.1.4.1. Scant reimbursement issues
• 5.2. Market Segmentation Analysis
• 5.3. Porter's Five Forces Analysis
  • 5.3.1. Threat of New Entrants
  • 5.3.2. Threat of Substitutes
  • 5.3.3. Bargaining Power of Customers
  • 5.3.4. Bargaining Power of Suppliers
  • 5.3.5. Industry Rivalry
• 5.4. PESTLE Analysis
  • 5.4.1. Political
  • 5.4.2. Economic
  • 5.4.3. Social
  • 5.4.4. Technological
  • 5.4.5. Legal
  • 5.4.6. Environmental

6. Biological Implants Market, by Product

• 6.1. Introduction
• 6.2. Allografts
• 6.3. Autografts
• 6.4. Xenografts

7. Biological Implants Market, by Mode of Administration

• 7.1. Introduction
• 7.2. Injectable
• 7.3. Surgical

8. Biological Implants Market, by Application

• 8.1. Introduction
• 8.2. Cardiovascular Implants
• 8.3. Orthopedic Implants
• 8.4. Soft Tissue Implants

9. Americas Biological Implants Market

• 9.1. Introduction
• 9.2. Argentina
• 9.3. Brazil
• 9.4. Canada
• 9.5. Mexico
• 9.6. United States

10. Asia-Pacific Biological Implants Market

• 10.1. Introduction
• 10.2. Australia
• 10.3. China
• 10.4. India
• 10.5. Indonesia
• 10.6. Japan
• 10.7. Malaysia
• 10.8. Philippines
• 10.9. Singapore
• 10.10. South Korea
• 10.11. Taiwan
• 10.12. Thailand
• 10.13. Vietnam

11. Europe, Middle East & Africa Biological Implants Market

• 11.1. Introduction
• 11.2. Denmark
• 11.3. Egypt
• 11.4. Finland
• 11.5. France
• 11.6. Germany
• 11.7. Israel
• 11.8. Italy
• 11.9. Netherlands
• 11.10. Nigeria
• 11.11. Norway
• 11.12. Poland
• 11.13. Qatar
• 11.14. Russia
• 11.15. Saudi Arabia
• 11.16. South Africa
• 11.17. Spain
• 11.18. Sweden
• 11.19. Switzerland
• 11.20. Turkey
• 11.21. United Arab Emirates
• 11.22. United Kingdom

12. Competitive Landscape

• 12.1. Market Share Analysis, 2023
• 12.2. FPNV Positioning Matrix, 2023
• 12.3. Competitive Scenario Analysis
• 12.4. Strategy Analysis & Recommendation

Companies Mentioned

• 1. AbbVie Inc.
• 2. Allografts.com
• 3. Alphatec Spine, Inc.
• 4. Altogen Labs
• 5. Auto Tissue Berlin GmbH
• 6. Baxter International, Inc.
• 7. BioPolymer GmbH & Co. KG
• 8. Citagenix Inc.
• 9. Conmed Corporation
• 10. CryoLife, Inc.
• 11. Edward LifeSciences Corporation
• 12. Integra LifeSciences Corporation
• 13. Johnson & Johnson Services, Inc.
• 14. KLS Martin, L.P. by Leibinger family
• 15. Medical Device Business Services, Inc.
• 16. Medtronic PLC
• 17. NuVasive, Inc. by Globus Medical Inc
• 18. RTI Surgical, Inc.
• 19. Sanara MedTech, Inc.
• 20. Stryker Corporation
• 21. Surgenex LLC
• 22. TissueTech, Inc.
• 23. Zimmer Biomet Holdings, Inc.